4 assets in Malignant Germ Cell Tumor Of Ovary

Therapeutic assets addressing Malignant Germ Cell Tumor Of Ovary, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Malignant Germ Cell Tumor Of Ovary	Children's Oncology Group	P3	BB (66)
Bleomycin Malignant Germ Cell Tumor Of Ovary	Children's Oncology Group	P3	BB (64)
Cis-Diamminedichloroplatinum Ii Malignant Germ Cell Tumor Of Ovary	Children's Oncology Group	P3	BB (64)
Etoposide Malignant Germ Cell Tumor Of Ovary	Children's Oncology Group	P3	BB (64)